{
    "clinical_study": {
        "@rank": "9749", 
        "brief_summary": {
            "textblock": "The purposes of this study\n\n        1. to compare the positivity of tuberculin skin test(TST) and QuantiFERON-TB Gold (QFT-G),\n           and determine the level of agreement between two tests in patients with rheumatic\n           diseases\n\n        2. to evaluate the difference in the occurrence of active TB in patients who receive both\n           QFT-G and TST compared with those who receive only TST for detecting of Latent\n           tuberculosis infection(LTBI) who are candidates of TNF inhibitors."
        }, 
        "brief_title": "The Usefulness of Interferon-\u03b3 Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Rheumatic Disease", 
            "Rheumatoid Arthritis", 
            "Ankylosing Spondylitis", 
            "Tuberculosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid", 
                "Rheumatic Diseases", 
                "Spondylitis", 
                "Spondylitis, Ankylosing", 
                "Tuberculosis", 
                "Latent Tuberculosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Study Assessment\n\n        1. The positive rates of QFT-G and TST as a screening test for LTBI\n\n             -  The positive rates of QFT-G and TST will be analyzed\n\n             -  Additional analysis will be performed according to the type of disease\n\n        2. The agreement between QFT-G and TST as a screening test for LTBI\n\n             -  The agreement between QFT-G and TST will be analyzed for patients with rheumatic\n                diseases who examined both QFT-G and TST\n\n             -  Additional analysis will be performed according to the type of disease\n\n        3. The correlation of the occurrence of active TB and two tests (QFT-G and TST)\n\n             -  The analysis of the correlation of the occurrence of active TB and two tests will\n                be conducted for patients who have experienced anti-TNF agents\n\n      3-1. The occurrence of active TB in accordance with results of TST\n\n      3-2. The occurrence of active TB in accordance with results of QFT-G\n\n      3-3. The difference in the occurrence of active TB in patients performed both QFT-G and TST\n      compared with those performed only TST for detecting of LTBI who are candidates of TNF\n      inhibitors (pilot study)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with rheumatic diseases who examined TST or QFT-G in Hanyang university\n             hospital from 2004 to 2010\n\n        Exclusion Criteria:\n\n          -  N/A"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "1) Estimation of the positive rates and agreement between QFT-G and TST\n\n          -  Approximately 2,000 patients with rheumatic diseases who examined TST or QFT-G in\n             Hanyang university hospital from 2004 to 2010 2) Determining the difference in the\n             occurrence of active TB in the TNF inhibitor user according to the screening and the\n             treatment of LTBI.\n\n          -  Approximately 400 patients with rheumatic diseases who received TST or QFT-G before\n             using anti-TNF agents in Hanyang university hospital from 2004 to 2010"
            }
        }, 
        "enrollment": {
            "#text": "2000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01685905", 
            "org_study_id": "TST_IGRA"
        }, 
        "intervention_browse": {
            "mesh_term": "Interferons"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "rheumatic disease, latent tuberculosis", 
        "lastchanged_date": "September 17, 2012", 
        "location": {
            "contact": {
                "email": "scbae@hanyang.ac.kr", 
                "last_name": "Sang-cheol Bae, MD", 
                "phone": "82-2-2290-9230"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "state": "Sung-dong Gu", 
                    "zip": "133-792"
                }, 
                "name": "Hanyang University Hospital for rheumatic disease"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "official_title": "Evaluation of the Usefulness of Interferon-\u03b3 Release Assays and Tuberculin Skin Test for Detection of Latent Mycobacterium Tuberculosis Infection in Korean Patients With Rheumatic Diseases", 
        "overall_contact": {
            "email": "scbae@hanyang.ac.kr", 
            "last_name": "Sang-cheol Bae, director", 
            "phone": "82-2-2290-8260"
        }, 
        "overall_official": {
            "affiliation": "Hanyang University Hospital for Rheumatic Disease", 
            "last_name": "Sang-cheol Bae, director", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The agreement between QuantiFERON-TB Gold(QFT-G) and tuberculin skin test(TST) as a screening test for latent tuberculosis infection(LTBI)", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01685905"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hanyang University", 
            "investigator_full_name": "Sang-Cheol Bae", 
            "investigator_title": "Professor, MD, PhD, MPH", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "The correlation of the occurrence of active Tuberculosis and two tests (QuantiFERON-TB Gold (QFT-G) and tuberculosis skin test(TST))", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "source": "Hanyang University", 
        "sponsors": {
            "collaborator": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Hanyang University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "September 2012"
    }
}